[Immunology in medical practice. XIX. Etiology and pathogenesis of auto-immune diseases]
- PMID: 10368716
[Immunology in medical practice. XIX. Etiology and pathogenesis of auto-immune diseases]
Abstract
In spite of the collection in the last 50 years of an enormous amount of knowledge about aetiology and pathogenesis of autoimmune diseases, important questions have not yet been answered (adequately), as shown by the very limited therapeutic application of this knowledge. Although autoreactive B and T cells are demonstrable in healthy individuals, this does under normal circumstances not lead to disease, for instance because necessary co-factors are lacking, B lymphocytes for antibody production require help from suitable autoreactive T helper cells, because of the action of T suppressor cells and due to anti-idiotypic antibodies and T cell receptors that may be directed against the antigen receptors of autoreactive B and T cells. Autoimmune diseases are sometimes subdivided into organspecific (e.g. Graves' disease) and systemic autoimmune diseases (e.g. disseminated lupus erythematosus). Roughly speaking there are two hypotheses concerning the aetiology or development of autoimmune diseases. The first hypothesis assumes a specific antigen as the driving factor, the second dysregulation of the immune system. The new insights into the pathogenesis of autoimmune diseases so far led to development of only few new drugs or therapies.
Similar articles
-
Infections and autoimmune diseases.J Autoimmun. 2005;25 Suppl:74-80. doi: 10.1016/j.jaut.2005.09.024. Epub 2005 Nov 8. J Autoimmun. 2005. PMID: 16278064 Review.
-
[B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].Fukuoka Igaku Zasshi. 2005 Apr;96(4):86-92. Fukuoka Igaku Zasshi. 2005. PMID: 15991605 Review. Japanese.
-
[Dendritic cells: orchestration of the immune response].Ann Biol Clin (Paris). 2000 Sep-Oct;58(5):541-56. Ann Biol Clin (Paris). 2000. PMID: 11022098 Review. French.
-
Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.Crit Rev Immunol. 2000;20(6):451-69. Crit Rev Immunol. 2000. PMID: 11396681 Review.
-
[Interleukin 10 in disseminated lupus erythematosus].J Soc Biol. 2002;196(1):19-21. J Soc Biol. 2002. PMID: 12134628 Review. French.
Publication types
MeSH terms
LinkOut - more resources
Medical